Copy
View this email in your browser

Rheumatology Evidence Update

27th June 2016

Do you have any research needs? 
Please do contact your Rheumatology Clinical Librarian, Pip Divall for any information and research assistance. 
0116 250 2309 or Pip.Divall@uhl-tr.nhs.uk
Belimumab for treating active autoantibody-positive systemic lupus erythematosus 
New and Updated Cochrane Systematic Reviews

Exercise therapy for chronic fatigue syndrome
Authors conclusions: Patients with CFS may generally benefit and feel less fatigued following exercise therapy, and no evidence suggests that exercise therapy may worsen outcomes. A positive effect with respect to sleep, physical function and self-perceived general health has been observed, but no conclusions for the outcomes of pain, quality of life, anxiety, depression, drop-out rate and health service resources were possible. The effectiveness of exercise therapy seems greater than that of pacing but similar to that of CBT. Randomised trials with low risk of bias are needed to investigate the type, duration and intensity of the most beneficial exercise intervention.

Biologic interventions for fatigue in rheumatoid arthritis
Authors' conclusions: Treatment with biologic interventions in patients with active RA can lead to a small to moderate improvement in fatigue. The magnitude of improvement is similar for anti-TNF and non-anti-TNF biologics. However, it is unclear whether the improvement results from a direct action of the biologics on fatigue or indirectly through reduction in inflammation, disease activity or some other mechanism.


Biologics or tofacitinib for rheumatoid arthritis in incomplete responders to methotrexate or other traditional disease-modifying anti-rheumatic drugs: a systematic review and network meta-analysis
Authors conclusions: Based primarily on RCTs of 6 months' to 12 months' duration, there is moderate quality evidence that the use of biologic+MTX/DMARD in people with rheumatoid arthritis who have failed to respond to MTX or other DMARDs results in clinically important improvement in function and higher ACR50 and remission rates, and increased risk of serious adverse events than the comparator (MTX/DMARD/PL; high quality evidence). Radiographic progression is slowed but its clinical relevance is uncertain. Results were inconclusive for whether biologics + MTX/DMARDs are associated with an increased risk of cancer or withdrawals due to adverse events.

Ankylosing spondylitis 
Ankylosing spondylitis may be associated with increased incidence of depression and anxiety (J Rheumatol 2016 Mar)
To access full text you may have to log in to your NHS Athens account (click here to register for free). If full text is not available then please email us to request a copy.
Other High Quality Research

Early rheumatoid arthritis treated with tocilizumab, methotrexate, or their combination (U-Act-Early): a multicentre, randomised, double-blind, double-dummy, strategy trial 

Effect of Macitentan on the Development of New Ischemic Digital Ulcers in Patients With Systemic Sclerosis: DUAL-1 and DUAL-2 Randomized Clinical Trials.

Association between psoriasis and chronic obstructive pulmonary disease: A systematic review and meta-analysis.

Predictors of flares in Systemic Lupus Erythematosus: Preventive therapeutic intervention based on serial anti-dsDNA antibodies assessment. Analysis of a monocentric cohort and literature review.

Withdrawal of biologic agents in rheumatoid arthritis: a systematic review and meta-analysis.

Short-Term Efficacy Reliably Predicts Long-Term Clinical Benefit in Rheumatoid Arthritis Clinical Trials as Demonstrated by Model-Based Meta-Analysis.

Patient-reported outcomes in trials of patients with polymyalgia rheumatica: a systematic literature review.

Anti-TNF discontinuation and tapering strategies in patients with axial spondyloarthritis: asystematic literature review.
UpToDate

What's new in Rheumatology
Leicester Publications 

Formulation and evaluation of anti-rheumatic dexibuprofen transdermal patches: a quality-by-design approach.
NHS England - Specialised Services clinical commissioning policies and service specification - 12th Wave

Royal College of Nursing - Administering subcutaneous methotrexate for inflammatory arthritis
NHS Behind the Headlines - media stories explained

Almost half of all UK adults may be living with chronic pain

Risky stem cell treatment 'halts progress of multiple sclerosis'
Table of Contents
Best Practice and Research Clinical Rheumatology
Clinical Rheumatology
Current Rheumatology reports
Journal of Clinical Rheumatology
Journal of Rheumatology
Modern Rheumatology
Pediatric Rheumatology
Rheumatology
Rheumatology International
Our mailing address is: pip.divall@uhl-tr.nhs.uk
 
Copyright © 2016 UHL Clinical Librarian Service, All rights reserved.
Share
Tweet
Forward






This email was sent to <<Email Address>>
why did I get this?    unsubscribe from this list    update subscription preferences
UHL Clinical Librarian Service · Education Centre · Glenfield Hospital · Leicester, LE3 9QP · United Kingdom

Email Marketing Powered by MailChimp